The effect of calcium channel blockers on the outcome of acute myeloid leukemia

Leukemia and Lymphoma

Volumn 55, Issue 12, 2014, Pages 2822-2829

  Chae, Young Kwang ^a   Dimou, Anastasios ^b   Pierce, Sherry ^a   Kantarjian, Hagop ^a   Andreeff, Michael ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Acute myeloid leukemia; Amlodipine; Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Beta blockers; Calcium channel blockers; Diltiazem

Indexed keywords

AMLODIPINE; CD34 ANTIGEN; DILTIAZEM; METOPROLOL; VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ASSESSMENT; COHORT ANALYSIS; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; TASK PERFORMANCE; TREATMENT RESPONSE; AGED; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTINEOPLASTIC AGENTS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84919448485     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.901513     Document Type: Article

References (30)

1. Ferrara F, Schifer CA. Acute myeloid leukaemia in adults. Lancet 2013;381:484-495.
2. Fischer K, Scholl C, Salat J, et al. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 1996;88:3962-3971.
3. Mrozek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classifcation? Blood 2007;109:431-448.
4. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-241.
5. Saltzman BS, Weiss NS, Sieh W, et al. Use of antihypertensive medications and breast cancer risk. Cancer Causes Control 2013; 24: 365-371.
6. Azoulay L, Assimes TL, Yin H, et al. Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One 2012; 7: e50893.
7. McMenamin UC, Murray LJ, Cantwell MM, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes Control 2012;23:221-230.
8. Barron TI, Connolly RM, Sharp L, et al. Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol 2011; 29: 2635-2644.
9. Lemeshow S, Sorensen HT, Phillips G, et al. Beta-blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev 2011;20:2273-2279.
10. Aksu S, Beyazit Y, Haznedaroglu IC, et al. Over-expression of angiotensin-converting enzyme (CD143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma 2006;47:891-896.
11. Zambidis ET, Park TS, Yu W, et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008;112:3601-3614.
12. De la Iglesia Inigo S, Lopez-Jorge CE, Gomez-Casares MT, et al. Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents. Leuk Res 2009;33:810-816.
13. Stanojkovic TP, Zizak Z, Mihailovic-Stanojevic N, et al. Inhibition of proliferation on some neoplastic cell lines-act of carvedilol and captopril. J Exp Clin Cancer Res 2005;24:387-395.
14. Hajighasemi F, Mirshafey A. In vitro sensitivity of leukemia cells to propranolol. J Clin Med Res 2009;1:144-149.
15. Prevarskaya N, Skryma R, Shuba Y Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011; 11: 609-618.
16. Wang W, Xiao J, Adachi M, et al. 4-Aminopyridine induces apoptosis of human acute myeloid leukemia cells via increasing [Ca2+]i through P2X7 receptor pathway. Cell Physiol Biochem 2011; 28:199-208.
17. Wang L, Xu B, White RE, et al. Growth factor-mediated K+ channel activity associated with human myeloblastic ML-1 cell proliferation. Am J Physiol 1997;273:C1657-C1665.
18. Wu ZZ, Li DP, Chen SR, et al. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem 2009; 284: 36453-36461.
19. Abdullaev IF, Bisaillon JM, Potier M, et al. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 2008; 103: 1289-1299.
20. Yanamandra N, Buzzeo RW, Gabriel M, et al. Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2 + inf ux through plasma membrane Ca2 + channels. J Pharmacol Exp Ter 2011;337:636-643.
21. Bogeski I, Kilch T, Niemeyer BA. ROS and SOCE: recent advances and controversies in the regulation of STIM and Orai. J Physiol 2012;590:4193-4200.
22. Huang Z, Li H, Guo F, et al. Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. Cell Physiol Biochem 2009;24:17-24.
23. Stepien O, Marche P. Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2000;279:H1220-H1227.
24. O'Donnell MR, Abboud CN, Altman J, et al. Acute myeloid leukemia. J Natl Compr Cancer Netw 2012; 10: 984-1021.
25. Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008; 9: 310-322.
26. Mason RP. Calcium channel blockers, apoptosis and cancer: is there a biologic relationship? J Am Coll Cardiol 1999;34:1857-1866.
27. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995;9:219-228.
28. Liang F, Schulte BA, Qu C, et al. Inhibition of the calcium-and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament f brocytes of the cochlea. Neuroscience 2005;135:263-271.
29. Leszczynski D, Zhao Y, Luokkamaki M, et al. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol 1994;145:1265-1270.
30. Kondo S, Yin D, Morimura T, et al. Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells. J Neurosurg 1995;82:469-474.